Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...

Multipotency of Hematopoietic Stem Cells

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...

Satellite Stem Cells and Muscular Dystrophy

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

UPLC-Q-TOF/MS, network pharmacology, molecular docking, and experimental validation to explore the mechanisms of toad clothing on rheumatoid arthritis.

Scientific reports·2025

Same author

Predictors of Seronegative Conversion After Centralized Management of Syphilis Patients in Shenzhen, China.

Frontiers in public health·2021

Same author

Development and utility of a close contact information management system for the COVID-19 pandemic.

BMC public health·2021

Same author

A Tubular Belt and a Möbius Strip with Dynamic Joints: Synthesis, Structure, and Host-Guest Chemistry.

Organic letters·2021

Same author

Preoperative Predictors of Prolonged Hospital Stay in Accelerated Rehabilitation for Patients Undergoing Orthopedic Surgery.

Bioinorganic chemistry and applications·2021

Same author

Asymmetric Non-Fullerene Small-Molecule Acceptors toward High-Performance Organic Solar Cells.

ACS central science·2021

Search research articles

Related Experiment Video

Updated: Jul 24, 2025

Ultrasound-guided Intracardiac Injection of Human Mesenchymal Stem Cells to Increase Homing to the Intestine for Use in Murine Models of Experimental Inflammatory Bowel Diseases

Ultrasound-guided Intracardiac Injection of Human Mesenchymal Stem Cells to Increase Homing to the Intestine for Use in Murine Models of Experimental Inflammatory Bowel Diseases

Published on: September 1, 2017

Mesenchymal Stem Cells: A Promising Treatment for Thymic Involution.

Zailing Yang¹, Yunxiao Peng², Jun Yuan¹

¹The Second People's Hospital of Guiyang, Medical Laboratory, Guiyang, Guizhou Province, China.

Advances in Experimental Medicine and Biology

|July 8, 2023

Summary

Mesenchymal stem cells (MSCs) show promise for treating thymus aging by regenerating immune function. Strategies like improved delivery methods enhance MSC survival and homing, boosting therapeutic efficacy for thymus regeneration.

Keywords:

Ageing Efficacy Mechanism Mesenchymal stem cells Thymus

More Related Videos

Author Spotlight: Advancing Hematopoietic Research Using Stromal Cell Isolation for Single Cell Sequencing

Author Spotlight: Advancing Hematopoietic Research Using Stromal Cell Isolation for Single Cell Sequencing

Published on: January 26, 2024

Assessment of the Immunomodulatory Properties of Human Mesenchymal Stem Cells MSCs

Assessment of the Immunomodulatory Properties of Human Mesenchymal Stem Cells MSCs

Published on: December 24, 2015

Related Experiment Videos

Last Updated: Jul 24, 2025

Ultrasound-guided Intracardiac Injection of Human Mesenchymal Stem Cells to Increase Homing to the Intestine for Use in Murine Models of Experimental Inflammatory Bowel Diseases

Ultrasound-guided Intracardiac Injection of Human Mesenchymal Stem Cells to Increase Homing to the Intestine for Use in Murine Models of Experimental Inflammatory Bowel Diseases

Published on: September 1, 2017

Author Spotlight: Advancing Hematopoietic Research Using Stromal Cell Isolation for Single Cell Sequencing

Author Spotlight: Advancing Hematopoietic Research Using Stromal Cell Isolation for Single Cell Sequencing

Published on: January 26, 2024

Assessment of the Immunomodulatory Properties of Human Mesenchymal Stem Cells MSCs

Assessment of the Immunomodulatory Properties of Human Mesenchymal Stem Cells MSCs

Published on: December 24, 2015

Area of Science:

Immunology
Regenerative Medicine
Cell Biology

Background:

The thymus, a primary immune organ, undergoes senescence, reducing T-cell production and immune function.
Mesenchymal stem cells (MSCs) offer potential for thymus senescence treatment due to their anti-inflammatory and antioxidant properties.
Current MSC therapy faces challenges including poor in vivo survival, short residence time, and low homing efficiency.

Approach:

Reviewing strategies to enhance mesenchymal stem cell (MSC) therapy for thymus senescence.
Investigating optimized cell dosing, transplantation frequency, and interval cycles.
Exploring advanced infusion techniques like biomaterial encapsulation (hydrogels/microgels) and iron oxide labeling to improve MSC survival and homing.

Key Points:

Optimizing MSC dosage, frequency, and intervals is crucial for therapeutic success.
Novel infusion methods, including hydrogels, microgels, and iron oxide labeling, enhance MSC survival and homing efficiency.
Improved MSC delivery can promote thymic epithelial cell regeneration and restore thymus function.

Conclusions:

Mesenchymal stem cell (MSC) therapy holds significant potential for combating thymus senescence.
Enhancing MSC survival and targeted delivery are key to maximizing therapeutic benefits.
Further research into optimized MSC strategies can restore thymus function and improve immune health.